Katie Gudiksen, Ph.D., is the Executive Editor for The Source on Healthcare Price and Competition. Dr. Gudiksen is an expert in healthcare reform and the drivers of healthcare costs, with a special interest in market consolidation and state policies to address market power. She has helped draft model legislation to improve state merger review processes and to prohibit anticompetitive terms in contracts between insurers and health systems. Her current work focuses on evaluating options states have to restrict excessive provider prices, including cost-growth benchmarks and state public options. Her past scholarship evaluated legal challenges to state laws aimed to improve affordability of pharmaceuticals.

Dr. Gudiksen is a graduate of the UCSF/UC Hastings Master of Science in Health Policy and Law program, where she studied policy solutions to promote competition in the pharmaceutical industry. Prior to joining The Source, she co-founded a cancer diagnostics start-up company and worked as Director of Technology where she developed technologies to detect biomarker signatures for aggressive prostate cancer. She also holds an A.M. and Ph.D. in Chemistry from Harvard University and a B.S. and B.A. from Hope College.

See her Profile Page and the Source Blog Author Page.

Amy Y. Gu, J.D., is the Managing Editor for The Source on Healthcare Price & Competition. She holds a J.D. from Loyola Law School and a B.A. in Economics from the University of California, Berkeley and brings to the Source a unique set of experience and perspective from both law and tech. As a licensed attorney, Amy practiced civil litigation and represented global pharmaceutical companies in FCPA compliance and discovery prior to joining The Source. She applies her legal expertise in her coverage and analysis of antitrust enforcement and healthcare litigation on The Source. Drawing upon her experience in co-founding an e-commerce platform, she further executes the mission of The Source in the design of the content and functionalities of the site to expand its scope and reach.

See her Profile Page and the Source Blog Author Page.

Robert Murray is President of Global Health Payment LLC, a management consulting firm specializing in the design and implementation of reimbursement systems for health care providers. In addition to his consulting responsibilities. Prior to his consulting experience Mr. Murray was appointed by the Governor of Maryland to serve as Executive Director of the Health Services Cost Review Commission (HSCRC) in 1994, Maryland’s all-payer hospital rate-setting agency. He served in that capacity for 17 years. Under Mr. Murray’s leadership the HSCRC initiated a number of innovative payment systems including global budgets for 10 rural hospitals, which served as the proto-type demonstration for the state’s hospital global budget demonstration with the Centers for Medicare and Medicaid Innovation (CMMI).

Since leaving the HSCRC, Mr. Murray has worked as a consultant developing hospital global budget payment models for the state of Vermont and a prospective payment system for small and rural hospitals for the state of Oregon. Mr. Murray also assisted CareFirst BlueCross BlueShield of Maryland with the development of its successful Patient-Centric Medical Home (PCMH) model. Internationally, he has assisted the Chinese Ministry of Health in the design of DRG-based payment systems and has worked as a Short-Term Consultant for the World Bank on a number of payment design-related projects.

His research interests include the development of administered provider payment systems, payment caps and other mechanisms to address the issue of high and rapidly increasing provider prices. He has written extensively on the history of state-based administered pricing systems in the U.S. He has a BA and MA in Economics and an MBA, from Stanford University in Palo Alto, California.

Jaime S. King is the John and Marylyn Mayo Chair in Health Law and Professor of Law at the University of Auckland in New Zealand. Prior to joining the University of Auckland, Professor King was the Bion M. Gregory Chair of Business Law and a Professor of Law at the University of California Hastings College of the Law. She served as the Associate Dean and Co-Director of the UCSF/UC Hastings Consortium on Law, Science, and Health Policy, the Co-Founder and Co-Director of the UCSF/UC Hastings Master’s Program in Health Law and Policy, and the Director of the J.D. Concentration on Law and Health Sciences.

Professor King is an expert in healthcare reform, specializing in some of the most complex challenges facing the U.S. healthcare system. Her current research focuses on the drivers of healthcare costs, with a special interest in market consolidation and efforts to improve transparency in healthcare pricing. Her past scholarship has also addressed questions of individual autonomy and the states’ police power, including but not limited to medical decision making and constitutional and regulatory questions regarding reproductive genetic testing.

In 2015, Professor King testified before the House Judiciary Subcommittee on Regulatory Reform, Commercial, and Antitrust Law on issues surrounding proposed health insurance mergers. She again testified in 2018 before the U.S. House of Representatives Subcommittee on Oversight and Investigations on state efforts to improve transparency in healthcare costs. Professor King is also a co-author of the 8th edition casebook of Health Law Cases and Problems. Currently, Professor King is a board member and the immediate Past President of the Board of the American Society of Law, Medicine, and Ethics.

See her Profile Page and the Source Blog Author Page.

Thomas Greaney, J.D. is a Visiting Professor at the University of California, Hastings College of the Law. Before joining UC Hastings, Professor Greaney was the Chester A. Myers Professor of Law and Director of the Center for Health Law Studies at Saint Louis University School of Law. He has written extensively on topics involving health law and policy, antitrust law, and health care financing and is co-author of the nation’s leading health law casebook and hornbook. He has testified several times before the Judiciary Committee of the U.S. House of Representatives and consulted for the FTC, U.S. Department of Justice and state attorneys general on health law enforcement issues. Prior to joining the SLU Law faculty, he served as an Assistant Chief in the Department of Justice, Antitrust Division, specializing in health care antitrust litigation, and completed a visiting professorship at Yale Law School. He has also been a Fulbright Fellow studying European Community competition law in Brussels, and has been a visiting scholar at Université Paris Dauphine in Paris, Seton Hall University, and the University of Minnesota. Professor Greaney was named Jay Healy Health Law Professor of the Year by the American Society of Law, Medicine and Ethics in 2007.

Professor Greaney received his B.A magna cum laude from Wesleyan University and his J.D. from Harvard Law School.

See his Profile Page.

Mary Mitchell is a Student Fellow for the The Source on Healthcare Price & Competition and a rising 3L at UC Law SF concentrating in Health Law and Policy. Her work with The Source focuses primarily on researching private equity acquisition in healthcare. Prior to joining The Source, Mary worked as a Summer Associate and then Law Clerk at Pritzker Levine, LLP. She also works with the Medical-Legal Partnership for Seniors Clinic, which, like The Source, is a project of the UCSF-UC Law Consortium on Law, Science, and Health Policy.

See her Author Page on the Source Blog.